Valuation: Huntsworth plc

Market Cap 412M 353M 331M 303M 568M 39.46B 575M 3.91B 1.52B 19.82B 1.55B 1.52B 65.57B P/E 2018
17.7x
P/E 2019 15.1x
Enterprise Value 528M 452M 423M 387M 727M 50.51B 736M 5B 1.95B 25.37B 1.98B 1.94B 83.92B EV / Sales 2018
2x
EV / Sales 2019 1.57x
Free-Float
-
Yield 2018
2.13%
Yield 2019 3.19%
Manager TitleAgeSince
Compliance Officer 59 2007-12-31
Director TitleAgeSince
Director/Board Member 42 2019-09-30
Director/Board Member - 2022-02-06
Date Insider Type Main position Quantity % Market Cap.
3/27/20 Sell

Director

608,059 0.1643%
3/27/20 Fiscal year

Director

1,472,392 0.3978%
3/12/20 Sell

Director

56,960 0.0154%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 508M
+0.49%+0.54%+29.30%+44.48% 29.84B
+0.54%-0.03%+12.98%+10.35% 24.02B
-1.41%-3.54%-40.24%-31.94% 10.53B
+5.00%+2.81% - - 7.4B
+0.34%-1.42%+59.65%+44.53% 5.88B
-0.28%-3.03%-1.75%-47.77% 5.69B
+3.47%+7.62%+6.40% - 5.54B
-2.61%+3.12%-27.57%+46.14% 4.16B
+0.64%-4.97%+4.35%+191.20% 3.37B
Average +0.62%+0.36%+5.39%+36.71% 9.69B
Weighted average by Cap. +0.63%+0.40%+11.66%+24.75%

Financials

2018 2019
Net sales 225M 193M 180M 165M 310M 21.52B 314M 2.13B 831M 10.81B 845M 826M 35.76B 265M 227M 212M 194M 365M 25.34B 369M 2.51B 978M 12.73B 995M 973M 42.11B
Net income 21.29M 18.24M 17.06M 15.62M 29.32M 2.04B 29.7M 202M 78.62M 1.02B 79.95M 78.21M 3.38B 20.3M 17.39M 16.27M 14.89M 27.95M 1.94B 28.31M 192M 74.95M 976M 76.21M 74.55M 3.23B
Net Debt 77M 65.96M 61.72M 56.49M 106M 7.37B 107M 729M 284M 3.7B 289M 283M 12.24B 115M 98.87M 92.51M 84.68M 159M 11.04B 161M 1.09B 426M 5.55B 433M 424M 18.35B
Logo Huntsworth plc
Huntsworth Limited is a United Kingdom-based intermediate holding company. The Company is engaged in healthcare and communication activities. The Company, through its subsidiaries, is focused on health that provides marketing and medical communications services to healthcare clients, which are primarily large and mid-size pharmaceuticals and biotechnology companies. It also provides a range of communications and advisory services, including strategic communications, public affairs, investor relations and consumer marketing. The Company’s financial instruments comprise bank loans, bank overdrafts, loan notes, and cash and short-term deposits. The Company’s geographical areas include the United Kingdom, Europe, the United States and the rest of the world. The Company’s subsidiaries operate in approximately 28 in the United Kingdom and Europe.
Employees
-